CD274 and cancer: The mechanisms for immune evasion mediated by inhibitory molecules are generally initiated by expressed ligands such as PD-L1 on cancer cells and some immune cells including DCs and TAMs engaging with its receptor PD-1 on T cells which in turn leads to T cell exhaustion and cancer cell escape from immune surveillance (14, 16, 17).